Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 202514

Marketing Status: Prescription
Active Ingredient: TAFLUPROST
Proprietary Name: ZIOPTAN
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: 0.0015%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AT
Application Number: N202514
Product Number: 001
Approval Date: Feb 10, 2012
Applicant Holder Full Name: AKORN OPERATING CO LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English